Columbia Research Enhanced Value ETF Rating $27.78 -0.19 (-0.68%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$27.81 +0.03 (+0.11%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Columbia Research Enhanced Value ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.REVS Aggregate RatingModerate Buy 2.60Holdings in REVS have an aggregate rating of Moderate Buy based on 553 analyst ratings issued in the past year covering 23 companies (41.4% of the portfolio).REVS Aggregate Price Target$27.78High Prediction$27.78Average Prediction$27.78Low Prediction$27.78Holdings in REVS have an aggregate price target of $27.78 and a range of $27.78 to $27.78 covering 23 companies (41.4% of the portfolio).REVS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Columbia Research Enhanced Value ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 REVS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.42%JPMJPMorgan Chase & Co.$306.88+0.4%4.5309 of 5 stars2.52$291.67 -5.0%23Trending News2.39%CSCOCisco Systems$66.53-1.7%4.899 of 5 stars2.63$74.53 12.0%24Positive News2.34%XOMExxon Mobil$112.21+0.1%4.8015 of 5 stars2.43$124.81 11.2%21Trending NewsAnalyst Upgrade2.32%PFEPfizer$23.91-3.8%4.9902 of 5 stars2.39$28.12 17.6%18Trending NewsHigh Trading Volume2.15%MOAltria Group$66.64+0.4%3.8161 of 5 stars2.00$60.88 -8.7%9Positive NewsOptions Volume2.09%GOOGLAlphabet$240.80+0.2%3.8857 of 5 stars2.84$221.44 -8.0%45Trending NewsAnalyst Upgrade2.02%LOWLowe's Companies$271.89-0.2%4.5841 of 5 stars2.58$284.13 4.5%26Positive NewsDividend IncreaseInsider Trade1.86%CRMSalesforce$242.68-1.5%4.9811 of 5 stars2.71$332.58 37.0%38Trending News1.77%MSMorgan Stanley$156.470.0%4.6249 of 5 stars2.47$138.25 -11.6%15Trending News1.73%CATCaterpillar$431.10-0.1%4.7384 of 5 stars2.83$457.20 6.1%18Positive News1.72%BLKBlackRock$1,124.34-0.9%4.6943 of 5 stars2.80$1,154.07 2.6%15Trending News1.70%GOOGAlphabet$241.38+0.2%4.5954 of 5 stars2.77$227.56 -5.7%30Trending NewsShort Interest ↓1.60%CVSCVS Health$75.00+0.4%4.9432 of 5 stars2.96$77.89 3.9%24Positive NewsAnalyst Downgrade1.50%CCitigroup$99.51+0.7%4.9572 of 5 stars2.67$96.96 -2.6%15Trending News1.44%CVXChevron$157.23-0.6%4.6689 of 5 stars2.36$164.80 4.8%22Positive News1.32%BMYBristol Myers Squibb$46.22-2.8%4.8681 of 5 stars2.24$56.38 22.0%21Positive News1.30%QCOMQUALCOMM$161.83+0.2%4.9165 of 5 stars2.54$182.82 13.0%24Trending News1.25%CICigna Group$302.71-1.0%5 of 5 stars3.00$374.76 23.8%19Positive NewsAnalyst Upgrade1.20%METAMeta Platforms$755.59+0.6%4.3885 of 5 stars2.96$822.41 8.8%47Trending NewsDividend Announcement1.17%UNPUnion Pacific$214.73-0.6%4.85 of 5 stars2.58$258.21 20.2%26Trending News1.14%NKENIKE$73.12-1.6%4.7854 of 5 stars2.76$78.67 7.6%33Trending News1.01%NEMNewmont$79.25-0.5%4.3886 of 5 stars2.71$67.38 -15.0%21Positive News0.97%PHParker-Hannifin$760.08-1.2%4.5882 of 5 stars2.68$770.94 1.4%19Positive News This page (NYSEARCA:REVS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REVS Stock Alerts